Novel agents in the treatment of lung cancer: Fourth Cambridge Conference.
The Fourth Cambridge Conference on Novel Agents in the Treatment of Lung Cancer was held in Cambridge, Massachusetts on September 29 to 30, 2006, to discuss ongoing clinical research of novel targeted agents for the treatment of non-small cell lung cancer, along with supportive basic and translational research into the molecular pathways implicated in cancer growth and resistance. New information, conclusions, and recommendations considered significant for the field by the program faculty are summarized below and presented at greater length in the individual articles and accompanying discussions that comprise the full conference proceedings.
Lynch
Thomas J
TJ
Division of Hematology/Oncology, Massachusetts General Hospital, 55 Fruit Street, Yawkey, 7th Floor, Suite 7601, Boston, MA 02114, USA. tlynch@partners.org .
Bonomi
Philip D
PD
Butts
Charles
C
Davies
Angela M
AM
Engelman
Jeffrey
J
Govindan
Ramaswamy
R
Herbst
Roy S
RS
Heymach
John V
JV
Johnson
Bruce E
BE
Martins
Renato G
RG
Perez-Soler
Roman
R
Riely
Gregory J
GJ
Sandler
Alan B
AB
Sequist
Lecia V
LV
Socinski
Mark A
MA
Wong
Kwok-Kin
KK
Hart
Carol S
CS
D000818:Animals; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy*
D000970:Antineoplastic Agents